Showing 20 of 10287 recruiting trials
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 6 sites📅 Started Aug 2025View details ↗
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months
👨⚕️ Julien M Nyombayire, MD, MSc, Center for Family Health Research📍 2 sites📅 Started Aug 2025View details ↗
Safety and Dystrophin Expression of SPOT-mRNA03 in Duchenne Muscular Dystrophy (DMD) Patients
RecruitingNCT07152834 ↗
Screening for Alpha-1 Antitrypsin Deficiency in Patients With Airway Obstruction
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
👨⚕️ Stephanie J. Lee, MD, MPH, Fred Hutch/University of Washington Cancer Consortium📍 3 sites📅 Started Aug 2025View details ↗
Study of EN-374 Gene Therapy in Participants With X-Linked Chronic Granulomatous Disease
Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
RecruitingNCT06894602 ↗
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
👨⚕️ Stephen Fletcher, DO, The University of Texas Health Science Center, Houston📍 1 site📅 Started Aug 2025View details ↗
PH Sensitive MRI Based Resections of Glioblastoma
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
👨⚕️ Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company📍 12 sites📅 Started Aug 2025View details ↗
Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease
RecruitingNCT07009132 ↗
Cholate Clearance in Fontan and Heart Failure
RecruitingNCT07156357 ↗
Surface EMG Testing on Swallowing in EoE Patients
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →